Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year.
Source: NYT Health - Category: Consumer Health News Authors: Stephanie Nolen Tags: Sexually Transmitted Diseases Vaccination and Immunization Developing Countries Cervical Cancer Human Papillomavirus (HPV) Women and Girls Medicine and Health Teenagers and Adolescence Children and Childhood Gardasil (Vaccine) Source Type: news
More News: African Health | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Childhood Cancer | Children | Gardasil | Genital Warts | Girls | Health | Human Papillomavirus (HPV) | Merck | STDs | Vaccines | Women